Luye Pharma Group Ltd (LUP) — Cash Flow Reinvestment Rate
Luye Pharma Group Ltd (LUP) has a Cash Flow Reinvestment Rate of 0.52x as of June 2023, reinvesting €180.80 Million (capex €0.00 plus investments €180.80 Million) from operating cash flow of €344.86 Million. Check Luye Pharma Group Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Luye Pharma Group Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Luye Pharma Group Ltd across 10 annual periods. Explore debt repayment capacity of Luye Pharma Group Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Luye Pharma Group Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Luye Pharma Group Ltd. For live market cap and broader valuation context, see Luye Pharma Group Ltd (LUP) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.03x | €3.62 Billion | €1.78 Billion | €1.00 Billion | ▼ -88.2% |
| 2024 | 17.16x | €2.88 Billion | €167.76 Million | €1.71 Billion | ▲ +1246.2% |
| 2023 | 1.27x | €2.03 Billion | €1.60 Billion | €1.17 Billion | ▼ -25.3% |
| 2022 | 1.71x | €2.82 Billion | €1.65 Billion | €1.16 Billion | ▼ -88.1% |
| 2021 | 14.33x | €2.61 Billion | €182.37 Million | €556.20 Million | ▲ +645.0% |
| 2020 | 1.92x | €1.99 Billion | €1.03 Billion | €692.81 Million | ▲ +106.8% |
| 2019 | 0.93x | €1.32 Billion | €1.42 Billion | €999.34 Million | ▼ -26.5% |
| 2018 | 1.27x | €1.32 Billion | €1.05 Billion | €728.16 Million | ▲ +61.2% |
| 2017 | 0.78x | €756.56 Million | €964.10 Million | €507.32 Million | ▼ -78.4% |
| 2016 | 3.64x | €2.15 Billion | €592.03 Million | €319.14 Million | — |